Combioxin S.A. is clinical-stage biotech company
Combioxin S.A. has raised $1.4M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
Combioxin S.A.'s investors include The Vijay and Marie Goradia Charitable Foundation, MassChallenge, Foundation for Innovation and Technology (FIT).
Combioxin S.A. is headquartered in Geneva, Switzerland.
Combioxin S.A. is clinical-stage biotech company
Combioxin S.A. is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Combioxin S.A. — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/combioxin-sa. Accessed August 14, 2026.
VCBacked. (2026). Combioxin S.A. — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/combioxin-sa
{{cite web |title=Combioxin S.A. — Funding & Investors |url=https://www.vcbacked.co/company/combioxin-sa |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated